PDF(430 KB)
PDF(430 KB)
PDF(430 KB)
我国药品上市后安全性信息变更的实施要点
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Analysis of the key implementation points for changes in safety information of marketed drugs in China
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
